The UF Health Cancer Center held its first-ever Physical Sciences Mini Retreat on Wednesday, Aug. 10, drawing a diverse group of more than 50 UF researchers. The goal was to stimulate new cancer-relevant collaborations between biologists, chemists, physicists, engineers and clinicians through scientific presentations and networking.
“We had a fantastic lineup of speakers representing many different departments from different colleges at UF,” said Rolf Renne, Ph.D., professor in the department of molecular genetics & microbiology and an organizer of the event. “It’s truly transdisciplinary science — we have physics, biophysics, chemistry. We also have a lot of engineering, which is unusual for cancer centers.”
The event was organized into two sessions that each featured seven speakers. Each speaker gave a presentation followed by time for audience questions. Speakers came from the departments of chemistry, medicinal chemistry, mechanical and aerospace engineering, biomedical engineering, chemical engineering, and pharmaceutics.
The event also included lunch and coffee breaks so researchers had a chance to talk. The retreat concluded with an announcement of a request for applications, or RFA, to offer attendees an opportunity to form new collaborations.
“The vision is that people start working together with others in more traditional cancer biology labs,” said Renne, who serves as associate director for basic sciences at the Cancer Center. “Traditionally, people who work in the chemistry department don’t regularly come for seminars here. That’s what we want to facilitate.”
“The vision is that people start working together with others in more traditional cancer biology labs.”
Rolf Renne, Ph.D.
Zhongwu Guo, Ph.D., professor and Scott Chair in the department of chemistry who organized the event with Renne, said he was pleased with the turnout and excited by the opportunities it provided researchers to strike up connections.
“There have been conversations already about ‘let’s do something together,’” Guo said during the event’s morning break. “I hope this will stimulate collaborations for cancer-related research between different scientists, especially between those from the physical sciences and those in the clinical sciences.”
Suzanne Lightsey, a doctoral student in the department of biomedical engineering, said the speakers did an outstanding job not only of describing their specific work, but also of relating how it can be applied to other fields.
“I like how the talks are high enough level that if it’s not your specialty, you can still follow along,” said Lightsey, who studies the barriers in solid tumors and how those barriers can be overcome to get immune cells in the tumor. “I definitely think seeing other people’s work is sparking ideas.”
After beginning her program during the pandemic, Lightsey said the in-person event was particularly meaningful.
“It’s rare that you get to see 20-plus faculty members speaking for just an afternoon,” she said. “So many of these faculty members, I’ve read their papers, I’ve seen their work, but I haven’t had a chance to meet them. This was such a great lineup.”
Thank you to our moderators and speakers who took the time to present lectures and participate in discussions!
Moderators/Organizers
Zhongwu Guo, Ph.D.
Professor and Scott Chair, Department of Chemistry
Rolf Renne, Ph.D.
Professor, Department of Molecular Genetics & Microbiology
Speakers
Matthew Eddy, Ph.D.
Assistant Professor, Department of Chemistry
Biophysical Investigations of Signalizing Proteins
Lina Cui, Ph.D.
Associate Professor, Department of Medicinal Chemistry
Synthetic Glycans in Molecular Imaging and Drug Discovery
Xin Tang, Ph.D.
Assistant Professor, Department of Mechanical and Aerospace Engineering
All-optical Interrogation of Cancer Mechanics and Drug Screening
Michael Harris, Ph.D.
Professor, Department of Chemistry
Structure, Function, and Inhibition of RNase P: An Essential Ribonucleoprotein Enzyme
W. Gregory Sawyer, Ph.D.
Professor, Department of Mechanical & Aerospace Engineering
Are Patient Explants a Promising Model for Personalized Cancer Treatment?
Gregory Hudalla, Ph.D.
Associate Professor, Department of Biomedical Engineering
Supramolecular Approaches for Localized Biotherapeutic Delivery
Guangrong Zheng, Ph.D.
Associate Professor, Department of Medicinal Chemistry
PROTAC Technology Offers Great Opportunities for Academic Drug Discovery
Pijush Jain, Ph.D.
Assistant Professor, Department of Chemical Engineering
Engineered CRISPR/Cas Systems as Next-Generation Diagnostics
Meghan Ferrall-Fairbanks, Ph.D.
Assistant Professor, Department of Biomedical Engineering
Leveraging Tumor Ecology to Optimize Cancer Treatment
Carlos Rinaldi-Ramos, Ph.D.
Professor and Chair, Department of Chemical Engineering
Tracking Nanoparticles and Cell Using Magnetic Particle Imaging
Jing Pan, Ph.D.
Assistant Professor, Department of Mechanical and Aerospace Engineering
Continuous Blood Biochemical Monitoring for Personalized Disease Management
Zhongwu Guo, Ph.D.
Professor and Scott Chair, Department of Chemistry
Carbohydrate-Based Therapeutic Cancer Vaccine
Carl Denard, Ph.D.
Assistant Professor, Department of Chemical Engineering
Redefining, Repurposing, and Reprogramming Post-Translational Modification Enzymes
Mei He, Ph.D.
Assistant Professor, Department of Pharmaceutics
Extracellular Vesicle Enabled Precision Drug Delivery